Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir
Authors
Christoph Sarrazin,
Hadas Dvory‐SobolEvguenia Svarovskaia,
Brian Doehle,
Phillip Pang,
Shu-Min Chuang,
Julie Ma,
Xiao Ding,
Nezam Afdhal,
Kris Kowdley,
Edward Gane,
Eric Lawitz,
Diana Brainard,
John McHutchison,
Michael Miller +13 authors
,
Hongmei Mo Tip Tip